

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of calcium ion import (GO:0090280) | 5.47413162 |
| 2 | glomerular basement membrane development (GO:0032836) | 4.61359975 |
| 3 | glomerulus development (GO:0032835) | 4.44512371 |
| 4 | regulation of gonadotropin secretion (GO:0032276) | 4.43266345 |
| 5 | cell differentiation involved in metanephros development (GO:0072202) | 4.42462226 |
| 6 | positive regulation of digestive system process (GO:0060456) | 4.30886466 |
| 7 | parturition (GO:0007567) | 4.25230579 |
| 8 | phenylpropanoid metabolic process (GO:0009698) | 4.23524962 |
| 9 | glomerular visceral epithelial cell development (GO:0072015) | 4.09581587 |
| 10 | positive regulation of steroid hormone secretion (GO:2000833) | 4.00885827 |
| 11 | positive regulation of catecholamine secretion (GO:0033605) | 3.96916860 |
| 12 | glucocorticoid biosynthetic process (GO:0006704) | 3.70087507 |
| 13 | regulation of cellular extravasation (GO:0002691) | 3.68093832 |
| 14 | germ cell migration (GO:0008354) | 3.65508720 |
| 15 | glomerular epithelial cell development (GO:0072310) | 3.55874396 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 3.51836501 |
| 17 | virion attachment to host cell (GO:0019062) | 3.51836501 |
| 18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.51669805 |
| 19 | positive regulation of respiratory burst (GO:0060267) | 3.45429424 |
| 20 | endothelium development (GO:0003158) | 3.44797297 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.42218804 |
| 22 | blood vessel maturation (GO:0001955) | 3.37438986 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.36714978 |
| 24 | response to interferon-beta (GO:0035456) | 3.35997995 |
| 25 | platelet dense granule organization (GO:0060155) | 3.30451960 |
| 26 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.29982387 |
| 27 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.29982387 |
| 28 | tooth mineralization (GO:0034505) | 3.28262820 |
| 29 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.27410090 |
| 30 | negative regulation of leukocyte migration (GO:0002686) | 3.25724057 |
| 31 | angiogenesis involved in wound healing (GO:0060055) | 3.24369808 |
| 32 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.21748444 |
| 33 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18561984 |
| 34 | regulation of axon extension involved in axon guidance (GO:0048841) | 3.16620413 |
| 35 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.08820749 |
| 36 | regulation of sequestering of triglyceride (GO:0010889) | 3.04382765 |
| 37 | opsonization (GO:0008228) | 3.04082757 |
| 38 | indole-containing compound catabolic process (GO:0042436) | 3.03363520 |
| 39 | indolalkylamine catabolic process (GO:0046218) | 3.03363520 |
| 40 | tryptophan catabolic process (GO:0006569) | 3.03363520 |
| 41 | regulation of corticosteroid hormone secretion (GO:2000846) | 3.02551363 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.01569567 |
| 43 | regulation of calcium ion import (GO:0090279) | 2.98108945 |
| 44 | toxin metabolic process (GO:0009404) | 2.97914019 |
| 45 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.96888860 |
| 46 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.94251080 |
| 47 | kidney mesenchyme development (GO:0072074) | 2.94073999 |
| 48 | lymph vessel development (GO:0001945) | 2.90482447 |
| 49 | oxygen transport (GO:0015671) | 2.89398025 |
| 50 | cell migration involved in heart development (GO:0060973) | 2.89296854 |
| 51 | lymphoid progenitor cell differentiation (GO:0002320) | 2.88568881 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87283393 |
| 53 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.86984405 |
| 54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86403371 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86403371 |
| 56 | behavioral response to nicotine (GO:0035095) | 2.85841766 |
| 57 | metanephric mesenchyme development (GO:0072075) | 2.84324049 |
| 58 | response to type I interferon (GO:0034340) | 2.84069085 |
| 59 | protein heterotrimerization (GO:0070208) | 2.83660984 |
| 60 | positive regulation of interleukin-17 production (GO:0032740) | 2.83359585 |
| 61 | type I interferon signaling pathway (GO:0060337) | 2.83210865 |
| 62 | cellular response to type I interferon (GO:0071357) | 2.83210865 |
| 63 | regulation of natural killer cell differentiation (GO:0032823) | 2.81607085 |
| 64 | response to interferon-alpha (GO:0035455) | 2.80676337 |
| 65 | negative regulation of norepinephrine secretion (GO:0010700) | 2.80379390 |
| 66 | regulation of axon guidance (GO:1902667) | 2.79639543 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77881954 |
| 68 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.77008483 |
| 69 | surfactant homeostasis (GO:0043129) | 2.75275999 |
| 70 | adhesion of symbiont to host (GO:0044406) | 2.73346779 |
| 71 | detection of other organism (GO:0098543) | 2.72479033 |
| 72 | negative regulation of metanephros development (GO:0072217) | 2.71909651 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 2.69331563 |
| 74 | negative regulation of protein autophosphorylation (GO:0031953) | 2.68078308 |
| 75 | response to gravity (GO:0009629) | 2.67219427 |
| 76 | locomotory exploration behavior (GO:0035641) | 2.66387867 |
| 77 | kynurenine metabolic process (GO:0070189) | 2.64375811 |
| 78 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.64262013 |
| 79 | complement activation (GO:0006956) | 2.63591808 |
| 80 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.62583019 |
| 81 | cellular response to interferon-beta (GO:0035458) | 2.62557448 |
| 82 | detection of bacterium (GO:0016045) | 2.62416317 |
| 83 | negative regulation of complement activation (GO:0045916) | 2.62008076 |
| 84 | complement activation, classical pathway (GO:0006958) | 2.61266513 |
| 85 | L-fucose catabolic process (GO:0042355) | 2.59386254 |
| 86 | fucose catabolic process (GO:0019317) | 2.59386254 |
| 87 | L-fucose metabolic process (GO:0042354) | 2.59386254 |
| 88 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.59017988 |
| 89 | phagocytosis, engulfment (GO:0006911) | 2.58978644 |
| 90 | glomerular filtration (GO:0003094) | 2.58659188 |
| 91 | positive regulation of odontogenesis (GO:0042482) | 2.58306974 |
| 92 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.58270888 |
| 93 | ovulation from ovarian follicle (GO:0001542) | 2.57798698 |
| 94 | regulation of antigen processing and presentation (GO:0002577) | 2.56161181 |
| 95 | lymphangiogenesis (GO:0001946) | 2.55958171 |
| 96 | arginine catabolic process (GO:0006527) | 2.55405190 |
| 97 | detection of external biotic stimulus (GO:0098581) | 2.54952577 |
| 98 | cellular response to exogenous dsRNA (GO:0071360) | 2.54599577 |
| 99 | regulation of endothelial cell differentiation (GO:0045601) | 2.54294745 |
| 100 | secretory granule organization (GO:0033363) | 2.51835789 |
| 101 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.51301778 |
| 102 | hemidesmosome assembly (GO:0031581) | 2.51189432 |
| 103 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.50722194 |
| 104 | cellular response to dexamethasone stimulus (GO:0071549) | 2.49320427 |
| 105 | positive regulation of vasculogenesis (GO:2001214) | 2.47400345 |
| 106 | drug catabolic process (GO:0042737) | 2.46399680 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 2.46006322 |
| 108 | facial nerve structural organization (GO:0021612) | 2.45483932 |
| 109 | regulation of vasculogenesis (GO:2001212) | 2.45459504 |
| 110 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.45432602 |
| 111 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.44440655 |
| 112 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.43894975 |
| 113 | response to corticosterone (GO:0051412) | 2.43431484 |
| 114 | smooth muscle tissue development (GO:0048745) | 2.42529122 |
| 115 | induction of positive chemotaxis (GO:0050930) | 2.41606126 |
| 116 | somite development (GO:0061053) | 2.41514285 |
| 117 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.41033056 |
| 118 | gland morphogenesis (GO:0022612) | 2.40362115 |
| 119 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.39846352 |
| 120 | negative regulation of protein localization to cell surface (GO:2000009) | 2.39193476 |
| 121 | regulation of dopamine secretion (GO:0014059) | 2.38985230 |
| 122 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.38627112 |
| 123 | tryptophan metabolic process (GO:0006568) | 2.38151644 |
| 124 | positive regulation of defense response to virus by host (GO:0002230) | 2.38103425 |
| 125 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.36002856 |
| 126 | regulation of glucocorticoid secretion (GO:2000849) | 2.35805252 |
| 127 | positive regulation of natural killer cell activation (GO:0032816) | 2.35728512 |
| 128 | definitive hemopoiesis (GO:0060216) | 2.35307397 |
| 129 | keratan sulfate catabolic process (GO:0042340) | 2.35218402 |
| 130 | RNA destabilization (GO:0050779) | 2.34818713 |
| 131 | renal filtration (GO:0097205) | 2.33500143 |
| 132 | negative regulation of interleukin-10 production (GO:0032693) | 2.33445387 |
| 133 | epoxygenase P450 pathway (GO:0019373) | 2.32063029 |
| 134 | protein activation cascade (GO:0072376) | 2.31549450 |
| 135 | negative regulation of humoral immune response (GO:0002921) | 2.31545650 |
| 136 | drug metabolic process (GO:0017144) | 2.30695858 |
| 137 | cellular response to cadmium ion (GO:0071276) | 2.30057519 |
| 138 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29842467 |
| 139 | gonadal mesoderm development (GO:0007506) | 2.29742893 |
| 140 | vitamin A metabolic process (GO:0006776) | 2.29623210 |
| 141 | exogenous drug catabolic process (GO:0042738) | 2.29610068 |
| 142 | cell differentiation involved in kidney development (GO:0061005) | 2.29212328 |
| 143 | arginine metabolic process (GO:0006525) | 2.29006767 |
| 144 | detection of light stimulus involved in visual perception (GO:0050908) | 2.28943026 |
| 145 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.28943026 |
| 146 | mesonephros development (GO:0001823) | 2.28683826 |
| 147 | regulation of neutrophil chemotaxis (GO:0090022) | 2.28627943 |
| 148 | regulation of neutrophil migration (GO:1902622) | 2.28627943 |
| 149 | low-density lipoprotein particle remodeling (GO:0034374) | 2.27912573 |
| 150 | regulation of monocyte chemotaxis (GO:0090025) | 2.27718250 |
| 151 | alanine transport (GO:0032328) | 2.26865633 |
| 152 | phenol-containing compound catabolic process (GO:0019336) | 2.26359752 |
| 153 | regulation of steroid hormone secretion (GO:2000831) | 2.25359457 |
| 154 | central nervous system myelination (GO:0022010) | 2.25193163 |
| 155 | axon ensheathment in central nervous system (GO:0032291) | 2.25193163 |
| 156 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.24283458 |
| 157 | response to dexamethasone (GO:0071548) | 2.23517969 |
| 158 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.23094451 |
| 159 | positive regulation of metanephros development (GO:0072216) | 2.23022648 |
| 160 | regulation of activation of Janus kinase activity (GO:0010533) | 2.22350888 |
| 161 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.22051018 |
| 162 | positive regulation of neutrophil migration (GO:1902624) | 2.22051018 |
| 163 | response to mineralocorticoid (GO:0051385) | 2.21682168 |
| 164 | regulation of triglyceride catabolic process (GO:0010896) | 2.20367371 |
| 165 | aromatic amino acid family catabolic process (GO:0009074) | 2.20299668 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.17846928 |
| 167 | regulation of T-helper 1 type immune response (GO:0002825) | 2.17276120 |
| 168 | macrophage differentiation (GO:0030225) | 2.16715089 |
| 169 | circadian sleep/wake cycle process (GO:0022410) | 2.16480968 |
| 170 | chemical homeostasis within a tissue (GO:0048875) | 2.15881699 |
| 171 | regulation of digestive system process (GO:0044058) | 2.15594079 |
| 172 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.15097482 |
| 173 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.14881449 |
| 174 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.14536176 |
| 175 | protein-lipid complex remodeling (GO:0034368) | 2.14211082 |
| 176 | macromolecular complex remodeling (GO:0034367) | 2.14211082 |
| 177 | plasma lipoprotein particle remodeling (GO:0034369) | 2.14211082 |
| 178 | acylglycerol homeostasis (GO:0055090) | 2.13978112 |
| 179 | triglyceride homeostasis (GO:0070328) | 2.13978112 |
| 180 | cell proliferation involved in kidney development (GO:0072111) | 2.13952068 |
| 181 | regulation of natural killer cell activation (GO:0032814) | 2.13766707 |
| 182 | positive regulation of axon extension (GO:0045773) | 2.13188637 |
| 183 | regulation of guanylate cyclase activity (GO:0031282) | 2.12818019 |
| 184 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.12698310 |
| 185 | behavioral response to ethanol (GO:0048149) | 2.11795244 |
| 186 | positive regulation of ion transmembrane transport (GO:0034767) | 2.11152233 |
| 187 | cellular ketone body metabolic process (GO:0046950) | 2.10677342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.22666034 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66488887 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53387536 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.14911812 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.11688872 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.08015724 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05319655 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04830384 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.01775959 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.00399896 |
| 11 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98404546 |
| 12 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.96113341 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94951802 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94110471 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91866718 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91279004 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.90346298 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84319391 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82353325 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.81065081 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.77092625 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.73867846 |
| 23 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.73285719 |
| 24 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.73144729 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71981449 |
| 26 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69258605 |
| 27 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68695936 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68695936 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.64964654 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.64050719 |
| 31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60337352 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57877559 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.57299811 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.54906031 |
| 35 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.52858716 |
| 36 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.51033036 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48639129 |
| 38 | VDR_22108803_ChIP-Seq_LS180_Human | 1.47883166 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47737335 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47584069 |
| 41 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.46466801 |
| 42 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45499620 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43259987 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39955507 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38566975 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38124942 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36468995 |
| 48 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.34748912 |
| 49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.31902127 |
| 50 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.31625972 |
| 51 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.29241863 |
| 52 | CJUN_26792858_Chip-Seq_BT549_Human | 1.29104738 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28919554 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.27813104 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.27554303 |
| 56 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.26113306 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26063375 |
| 58 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25915278 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25791082 |
| 60 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24723381 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24483026 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24414280 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23924834 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23924834 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.22878372 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.21660848 |
| 67 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20645983 |
| 68 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20334467 |
| 69 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19244127 |
| 70 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18784320 |
| 71 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.18783206 |
| 72 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18676899 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.18120962 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17505847 |
| 75 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17292976 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16774609 |
| 77 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16482385 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15563648 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14231949 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13415929 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12532121 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11377913 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10467804 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09711853 |
| 85 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08959838 |
| 86 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08413574 |
| 87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.06717017 |
| 88 | P300_19829295_ChIP-Seq_ESCs_Human | 1.06454601 |
| 89 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06078425 |
| 90 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.05891370 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05400794 |
| 92 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05124166 |
| 93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04726055 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03965600 |
| 95 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.03549219 |
| 96 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02920959 |
| 97 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02758925 |
| 98 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02688670 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01683586 |
| 100 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99534360 |
| 101 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99276253 |
| 102 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.99270999 |
| 103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98405104 |
| 104 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.98331595 |
| 105 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.98256286 |
| 106 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97859963 |
| 107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97852107 |
| 108 | ERA_21632823_ChIP-Seq_H3396_Human | 0.97403444 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96844903 |
| 110 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96765635 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96757293 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96360079 |
| 113 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94529279 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93341961 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92730536 |
| 116 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92232318 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92022532 |
| 118 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91855457 |
| 119 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91372518 |
| 120 | AR_20517297_ChIP-Seq_VCAP_Human | 0.91197653 |
| 121 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91195374 |
| 122 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91195374 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90774761 |
| 124 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90742189 |
| 125 | KDM2B_26808549_Chip-Seq_REH_Human | 0.90702238 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90444266 |
| 127 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89361098 |
| 128 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89275109 |
| 129 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.88231699 |
| 130 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88018283 |
| 131 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.87561118 |
| 132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.87470086 |
| 133 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.87276417 |
| 134 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87047302 |
| 135 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86614081 |
| 136 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86597365 |
| 137 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86360022 |
| 138 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.86139165 |
| 139 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86001806 |
| 140 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85975994 |
| 141 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.85812431 |
| 142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.85568242 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85383481 |
| 144 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85221744 |
| 145 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.84884975 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84800094 |
| 147 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83568488 |
| 148 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83418819 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83317870 |
| 150 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83060696 |
| 151 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82531468 |
| 152 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81814646 |
| 153 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81116532 |
| 154 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79003358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 5.61136008 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.47469590 |
| 3 | MP0003724_increased_susceptibility_to | 3.00691748 |
| 4 | MP0000685_abnormal_immune_system | 2.85159776 |
| 5 | MP0003011_delayed_dark_adaptation | 2.74144489 |
| 6 | MP0005503_abnormal_tendon_morphology | 2.72724320 |
| 7 | MP0005275_abnormal_skin_tensile | 2.64827843 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.48572131 |
| 9 | MP0003195_calcinosis | 2.38790553 |
| 10 | MP0009785_altered_susceptibility_to | 2.37536000 |
| 11 | MP0004272_abnormal_basement_membrane | 2.30265723 |
| 12 | MP0001501_abnormal_sleep_pattern | 2.25089330 |
| 13 | MP0005360_urolithiasis | 2.17157470 |
| 14 | MP0001958_emphysema | 2.16361838 |
| 15 | MP0006082_CNS_inflammation | 2.07279113 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.07009985 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 1.99422086 |
| 18 | MP0004510_myositis | 1.98881844 |
| 19 | MP0008775_abnormal_heart_ventricle | 1.98761778 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.92990285 |
| 21 | MP0003279_aneurysm | 1.91348873 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 1.88043116 |
| 23 | MP0005387_immune_system_phenotype | 1.87407433 |
| 24 | MP0001790_abnormal_immune_system | 1.87407433 |
| 25 | MP0001346_abnormal_lacrimal_gland | 1.86996348 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.82560057 |
| 27 | MP0001542_abnormal_bone_strength | 1.81524889 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.78306444 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.74905108 |
| 30 | MP0005671_abnormal_response_to | 1.70763118 |
| 31 | MP0005025_abnormal_response_to | 1.70561882 |
| 32 | MP0004381_abnormal_hair_follicle | 1.65999274 |
| 33 | MP0005365_abnormal_bile_salt | 1.62233355 |
| 34 | MP0003646_muscle_fatigue | 1.60391286 |
| 35 | MP0002419_abnormal_innate_immunity | 1.60227164 |
| 36 | MP0000920_abnormal_myelination | 1.54755440 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.52877822 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.49887892 |
| 39 | MP0001851_eye_inflammation | 1.46779620 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.44791408 |
| 41 | MP0004043_abnormal_pH_regulation | 1.44155632 |
| 42 | MP0000681_abnormal_thyroid_gland | 1.44081166 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.42730268 |
| 44 | MP0001873_stomach_inflammation | 1.40773674 |
| 45 | MP0002166_altered_tumor_susceptibility | 1.36903303 |
| 46 | MP0003329_amyloid_beta_deposits | 1.36370348 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.33636343 |
| 48 | MP0001800_abnormal_humoral_immune | 1.33347901 |
| 49 | MP0002060_abnormal_skin_morphology | 1.32642801 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.32082872 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.32082872 |
| 52 | MP0003436_decreased_susceptibility_to | 1.31962930 |
| 53 | MP0000343_altered_response_to | 1.29000947 |
| 54 | MP0004084_abnormal_cardiac_muscle | 1.28720651 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.28079636 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.28021185 |
| 57 | MP0002723_abnormal_immune_serum | 1.27603270 |
| 58 | MP0009764_decreased_sensitivity_to | 1.22604620 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.22495544 |
| 60 | MP0000383_abnormal_hair_follicle | 1.21216730 |
| 61 | MP0005409_darkened_coat_color | 1.20864802 |
| 62 | MP0005310_abnormal_salivary_gland | 1.19903027 |
| 63 | MP0001661_extended_life_span | 1.19327124 |
| 64 | MP0004130_abnormal_muscle_cell | 1.18850615 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.17246002 |
| 66 | MP0003950_abnormal_plasma_membrane | 1.17158691 |
| 67 | MP0002933_joint_inflammation | 1.16693144 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 1.16451095 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.16088277 |
| 70 | MP0009840_abnormal_foam_cell | 1.15605770 |
| 71 | MP0001819_abnormal_immune_cell | 1.15315677 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.14799492 |
| 73 | MP0005670_abnormal_white_adipose | 1.14552764 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.12300971 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.12061956 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 1.09554277 |
| 77 | MP0005646_abnormal_pituitary_gland | 1.08490749 |
| 78 | MP0002009_preneoplasia | 1.08393680 |
| 79 | MP0003045_fibrosis | 1.08273884 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.08072491 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.07911929 |
| 82 | MP0002971_abnormal_brown_adipose | 1.06579666 |
| 83 | MP0006276_abnormal_autonomic_nervous | 1.06177209 |
| 84 | MP0006054_spinal_hemorrhage | 1.05686636 |
| 85 | MP0005332_abnormal_amino_acid | 1.05269183 |
| 86 | MP0003828_pulmonary_edema | 1.03940796 |
| 87 | MP0009384_cardiac_valve_regurgitation | 1.03488340 |
| 88 | * MP0001845_abnormal_inflammatory_respons | 1.02349819 |
| 89 | MP0004858_abnormal_nervous_system | 1.02165288 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 1.01855491 |
| 91 | MP0000003_abnormal_adipose_tissue | 1.01419590 |
| 92 | MP0005623_abnormal_meninges_morphology | 1.00756904 |
| 93 | MP0005647_abnormal_sex_gland | 0.98648631 |
| 94 | MP0005253_abnormal_eye_physiology | 0.97977866 |
| 95 | MP0002006_tumorigenesis | 0.97067888 |
| 96 | MP0002133_abnormal_respiratory_system | 0.96329301 |
| 97 | MP0005388_respiratory_system_phenotype | 0.96329301 |
| 98 | MP0002108_abnormal_muscle_morphology | 0.96208046 |
| 99 | MP0005164_abnormal_response_to | 0.96170119 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.95224562 |
| 101 | MP0009278_abnormal_bone_marrow | 0.94004757 |
| 102 | MP0005448_abnormal_energy_balance | 0.93134661 |
| 103 | MP0008872_abnormal_physiological_respon | 0.92641023 |
| 104 | MP0004782_abnormal_surfactant_physiolog | 0.92313629 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.91305401 |
| 106 | MP0008004_abnormal_stomach_pH | 0.90971105 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.89953775 |
| 108 | MP0008469_abnormal_protein_level | 0.89188193 |
| 109 | MP0004085_abnormal_heartbeat | 0.88736046 |
| 110 | MP0009780_abnormal_chondrocyte_physiolo | 0.88082717 |
| 111 | MP0005165_increased_susceptibility_to | 0.88049316 |
| 112 | MP0005535_abnormal_body_temperature | 0.87914243 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.87253958 |
| 114 | MP0001756_abnormal_urination | 0.87094235 |
| 115 | MP0001968_abnormal_touch/_nociception | 0.86977123 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.86775075 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.86640221 |
| 118 | MP0003959_abnormal_lean_body | 0.86626598 |
| 119 | MP0005390_skeleton_phenotype | 0.86132500 |
| 120 | MP0002405_respiratory_system_inflammati | 0.85499794 |
| 121 | MP0000604_amyloidosis | 0.83937774 |
| 122 | MP0000716_abnormal_immune_system | 0.83847074 |
| 123 | MP0004484_altered_response_of | 0.83821672 |
| 124 | MP0000566_synostosis | 0.82902209 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.82180056 |
| 126 | MP0009333_abnormal_splenocyte_physiolog | 0.81443702 |
| 127 | MP0003690_abnormal_glial_cell | 0.81183000 |
| 128 | MP0004147_increased_porphyrin_level | 0.80676860 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.79994930 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.79942188 |
| 131 | MP0005620_abnormal_muscle_contractility | 0.79930436 |
| 132 | MP0006138_congestive_heart_failure | 0.79488856 |
| 133 | MP0003638_abnormal_response/metabolism_ | 0.79422277 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.79123147 |
| 135 | MP0009745_abnormal_behavioral_response | 0.78050531 |
| 136 | MP0002127_abnormal_cardiovascular_syste | 0.77497149 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.77385387 |
| 138 | MP0001919_abnormal_reproductive_system | 0.77131988 |
| 139 | MP0003075_altered_response_to | 0.76819373 |
| 140 | MP0004883_abnormal_blood_vessel | 0.76637883 |
| 141 | MP0002396_abnormal_hematopoietic_system | 0.74875431 |
| 142 | MP0009250_abnormal_appendicular_skeleto | 0.74183811 |
| 143 | MP0002972_abnormal_cardiac_muscle | 0.73800774 |
| 144 | MP0001905_abnormal_dopamine_level | 0.73514506 |
| 145 | MP0003448_altered_tumor_morphology | 0.71742262 |
| 146 | MP0005167_abnormal_blood-brain_barrier | 0.71636741 |
| 147 | MP0009046_muscle_twitch | 0.71383536 |
| 148 | MP0005075_abnormal_melanosome_morpholog | 0.71118609 |
| 149 | MP0005171_absent_coat_pigmentation | 0.71035271 |
| 150 | MP0002168_other_aberrant_phenotype | 0.70839963 |
| 151 | MP0003191_abnormal_cellular_cholesterol | 0.70455364 |
| 152 | MP0005375_adipose_tissue_phenotype | 0.70113700 |
| 153 | MP0000751_myopathy | 0.70018649 |
| 154 | MP0002249_abnormal_larynx_morphology | 0.69714053 |
| 155 | MP0001970_abnormal_pain_threshold | 0.69630377 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.69568095 |
| 157 | MP0000249_abnormal_blood_vessel | 0.69415534 |
| 158 | MP0000538_abnormal_urinary_bladder | 0.69403408 |
| 159 | MP0000613_abnormal_salivary_gland | 0.69014641 |
| 160 | MP0001853_heart_inflammation | 0.67678107 |
| 161 | MP0000230_abnormal_systemic_arterial | 0.65641293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 4.35715626 |
| 2 | Abnormality of complement system (HP:0005339) | 4.32965670 |
| 3 | Increased corneal curvature (HP:0100692) | 4.21598856 |
| 4 | Keratoconus (HP:0000563) | 4.21598856 |
| 5 | Broad metatarsal (HP:0001783) | 4.04414994 |
| 6 | Myositis (HP:0100614) | 3.89330242 |
| 7 | Chronic otitis media (HP:0000389) | 3.59760689 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 3.57978302 |
| 9 | Aortic dissection (HP:0002647) | 3.57330271 |
| 10 | Mesangial abnormality (HP:0001966) | 3.56084026 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.53814990 |
| 12 | Glomerulonephritis (HP:0000099) | 3.47282981 |
| 13 | Hypoproteinemia (HP:0003075) | 3.32866562 |
| 14 | Hypothermia (HP:0002045) | 3.21777385 |
| 15 | Polyphagia (HP:0002591) | 3.10658426 |
| 16 | Decreased circulating renin level (HP:0003351) | 3.07702675 |
| 17 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.97551048 |
| 18 | Nephritis (HP:0000123) | 2.94478710 |
| 19 | Keratoconjunctivitis (HP:0001096) | 2.92081651 |
| 20 | Eczematoid dermatitis (HP:0000976) | 2.86391782 |
| 21 | Nasolacrimal duct obstruction (HP:0000579) | 2.84424901 |
| 22 | Orchitis (HP:0100796) | 2.83798535 |
| 23 | Right ventricular cardiomyopathy (HP:0011663) | 2.82046811 |
| 24 | Joint stiffness (HP:0001387) | 2.80606925 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 2.79529349 |
| 26 | Spontaneous hematomas (HP:0007420) | 2.78956770 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.78545097 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78403348 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78403348 |
| 30 | Premature rupture of membranes (HP:0001788) | 2.78394863 |
| 31 | Purpura (HP:0000979) | 2.75321505 |
| 32 | Bone cyst (HP:0012062) | 2.75265453 |
| 33 | Pulmonary artery stenosis (HP:0004415) | 2.73252136 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.70355908 |
| 35 | Optic neuritis (HP:0100653) | 2.70355908 |
| 36 | Weak cry (HP:0001612) | 2.66946105 |
| 37 | Ankle contracture (HP:0006466) | 2.66560751 |
| 38 | Hydroxyprolinuria (HP:0003080) | 2.65379499 |
| 39 | Abnormality of proline metabolism (HP:0010907) | 2.65379499 |
| 40 | Atrophic scars (HP:0001075) | 2.64327312 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.61666537 |
| 42 | Hyperlipoproteinemia (HP:0010980) | 2.57179251 |
| 43 | Xanthomatosis (HP:0000991) | 2.56730660 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 2.56052410 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.55600864 |
| 46 | Delayed CNS myelination (HP:0002188) | 2.55011712 |
| 47 | Aortic valve stenosis (HP:0001650) | 2.53696645 |
| 48 | Follicular hyperkeratosis (HP:0007502) | 2.51975387 |
| 49 | Hyperventilation (HP:0002883) | 2.50784787 |
| 50 | Facial shape deformation (HP:0011334) | 2.49246070 |
| 51 | Potter facies (HP:0002009) | 2.49246070 |
| 52 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.48505167 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.45941499 |
| 54 | Nonprogressive disorder (HP:0003680) | 2.43620386 |
| 55 | Recurrent skin infections (HP:0001581) | 2.37488155 |
| 56 | Abnormality of the columella (HP:0009929) | 2.37112465 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.36688264 |
| 58 | Petechiae (HP:0000967) | 2.35440592 |
| 59 | Attenuation of retinal blood vessels (HP:0007843) | 2.34884469 |
| 60 | Interstitial pulmonary disease (HP:0006530) | 2.30262118 |
| 61 | Type II lissencephaly (HP:0007260) | 2.28464500 |
| 62 | Type 2 muscle fiber atrophy (HP:0003554) | 2.28256945 |
| 63 | Prolonged QT interval (HP:0001657) | 2.26859819 |
| 64 | Aortic aneurysm (HP:0004942) | 2.25846747 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.25139432 |
| 66 | Large for gestational age (HP:0001520) | 2.24601544 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.24125956 |
| 68 | Onycholysis (HP:0001806) | 2.23955626 |
| 69 | Chronic sinusitis (HP:0011109) | 2.23660562 |
| 70 | Pancreatic cysts (HP:0001737) | 2.22960067 |
| 71 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21528124 |
| 72 | Metaphyseal dysplasia (HP:0100255) | 2.19288324 |
| 73 | Arterial tortuosity (HP:0005116) | 2.15831853 |
| 74 | Premature skin wrinkling (HP:0100678) | 2.15434099 |
| 75 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14636230 |
| 76 | Abnormality of alanine metabolism (HP:0010916) | 2.14636230 |
| 77 | Hyperalaninemia (HP:0003348) | 2.14636230 |
| 78 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.14259156 |
| 79 | Spondylolisthesis (HP:0003302) | 2.14147469 |
| 80 | Hematochezia (HP:0002573) | 2.14022229 |
| 81 | Congenital, generalized hypertrichosis (HP:0004540) | 2.12335343 |
| 82 | Tubular atrophy (HP:0000092) | 2.09282713 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.08029080 |
| 84 | Parakeratosis (HP:0001036) | 2.07502976 |
| 85 | Prominent supraorbital ridges (HP:0000336) | 2.07433861 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.07368274 |
| 87 | Opisthotonus (HP:0002179) | 2.06482700 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 2.04735771 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03616496 |
| 90 | Abnormality of the costochondral junction (HP:0000919) | 2.02817182 |
| 91 | Wrist flexion contracture (HP:0001239) | 2.02436070 |
| 92 | Panhypogammaglobulinemia (HP:0003139) | 2.00472472 |
| 93 | Soft skin (HP:0000977) | 2.00011852 |
| 94 | Vertebral compression fractures (HP:0002953) | 1.99472541 |
| 95 | Molar tooth sign on MRI (HP:0002419) | 1.99461683 |
| 96 | Abnormality of midbrain morphology (HP:0002418) | 1.99461683 |
| 97 | Abolished electroretinogram (ERG) (HP:0000550) | 1.97977912 |
| 98 | Cystic liver disease (HP:0006706) | 1.97972890 |
| 99 | Short hallux (HP:0010109) | 1.96620578 |
| 100 | Retinal dysplasia (HP:0007973) | 1.96002331 |
| 101 | Abnormality of renin-angiotensin system (HP:0000847) | 1.95635963 |
| 102 | Clumsiness (HP:0002312) | 1.95583751 |
| 103 | Fragile skin (HP:0001030) | 1.95256491 |
| 104 | Aortic regurgitation (HP:0001659) | 1.95189383 |
| 105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94776898 |
| 106 | Malnutrition (HP:0004395) | 1.94145217 |
| 107 | Vascular tortuosity (HP:0004948) | 1.93721206 |
| 108 | Aplasia cutis congenita (HP:0001057) | 1.93572667 |
| 109 | Abnormality of the frontal sinuses (HP:0002687) | 1.93035806 |
| 110 | Metabolic alkalosis (HP:0200114) | 1.92428263 |
| 111 | Atrial fibrillation (HP:0005110) | 1.92417553 |
| 112 | Hypoplasia of the iris (HP:0007676) | 1.92120210 |
| 113 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91405169 |
| 114 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91405169 |
| 115 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91405169 |
| 116 | Complement deficiency (HP:0004431) | 1.90823269 |
| 117 | Ventricular tachycardia (HP:0004756) | 1.90626988 |
| 118 | Abnormal eating behavior (HP:0100738) | 1.90603502 |
| 119 | Stridor (HP:0010307) | 1.90598750 |
| 120 | Hemoptysis (HP:0002105) | 1.90497232 |
| 121 | Polydipsia (HP:0001959) | 1.90399322 |
| 122 | Abnormal drinking behavior (HP:0030082) | 1.90399322 |
| 123 | Corneal dystrophy (HP:0001131) | 1.89901407 |
| 124 | Eosinophilia (HP:0001880) | 1.89868043 |
| 125 | Abnormality of the nasolacrimal system (HP:0000614) | 1.89402805 |
| 126 | Abnormality of molar morphology (HP:0011070) | 1.89147003 |
| 127 | Abnormality of molar (HP:0011077) | 1.89147003 |
| 128 | Lymphangioma (HP:0100764) | 1.88911323 |
| 129 | Abnormal albumin level (HP:0012116) | 1.88846968 |
| 130 | Hypoalbuminemia (HP:0003073) | 1.88846968 |
| 131 | Autoimmune thrombocytopenia (HP:0001973) | 1.88594860 |
| 132 | Inability to walk (HP:0002540) | 1.87686585 |
| 133 | Bradycardia (HP:0001662) | 1.87613135 |
| 134 | Abnormal urine output (HP:0012590) | 1.87381988 |
| 135 | Type 1 muscle fiber predominance (HP:0003803) | 1.87293572 |
| 136 | Vacuolated lymphocytes (HP:0001922) | 1.86713721 |
| 137 | Abnormality of the lacrimal duct (HP:0011481) | 1.86412030 |
| 138 | Abnormal hair whorl (HP:0010721) | 1.86408264 |
| 139 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.86188650 |
| 140 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.84297395 |
| 141 | Absent speech (HP:0001344) | 1.84245177 |
| 142 | Amyloidosis (HP:0011034) | 1.83918270 |
| 143 | Thyroid-stimulating hormone excess (HP:0002925) | 1.83676130 |
| 144 | Meningitis (HP:0001287) | 1.83212002 |
| 145 | Hepatosplenomegaly (HP:0001433) | 1.82971018 |
| 146 | Vasculitis (HP:0002633) | 1.81540809 |
| 147 | Bulbous nose (HP:0000414) | 1.81470430 |
| 148 | Muscle fiber atrophy (HP:0100295) | 1.81449381 |
| 149 | Decreased central vision (HP:0007663) | 1.80844780 |
| 150 | Facial diplegia (HP:0001349) | 1.80836653 |
| 151 | Milia (HP:0001056) | 1.80093375 |
| 152 | Cerebral hemorrhage (HP:0001342) | 1.79652812 |
| 153 | Chondrocalcinosis (HP:0000934) | 1.79327498 |
| 154 | Protrusio acetabuli (HP:0003179) | 1.78929219 |
| 155 | Peritonitis (HP:0002586) | 1.78847541 |
| 156 | Syncope (HP:0001279) | 1.78679187 |
| 157 | Stage 5 chronic kidney disease (HP:0003774) | 1.76453227 |
| 158 | Ulnar claw (HP:0001178) | 1.76163082 |
| 159 | Abnormality of the renal medulla (HP:0100957) | 1.76054280 |
| 160 | Myocardial infarction (HP:0001658) | 1.74963421 |
| 161 | Inflammation of the large intestine (HP:0002037) | 1.74583245 |
| 162 | Nephronophthisis (HP:0000090) | 1.74371260 |
| 163 | Abnormal pupillary function (HP:0007686) | 1.73618029 |
| 164 | Abnormality of Sharpey fibers (HP:0100685) | 1.73464710 |
| 165 | Primary atrial arrhythmia (HP:0001692) | 1.73077347 |
| 166 | White forelock (HP:0002211) | 1.72692359 |
| 167 | Abnormal glucose tolerance (HP:0001952) | 1.72607564 |
| 168 | Patchy hypopigmentation of hair (HP:0011365) | 1.72564460 |
| 169 | Recurrent fungal infections (HP:0002841) | 1.72549902 |
| 170 | Asymmetric septal hypertrophy (HP:0001670) | 1.71997185 |
| 171 | Abnormality of dentin (HP:0010299) | 1.71861075 |
| 172 | Mucopolysacchariduria (HP:0008155) | 1.71438598 |
| 173 | Dysostosis multiplex (HP:0000943) | 1.70207738 |
| 174 | Cerebral palsy (HP:0100021) | 1.69126653 |
| 175 | Palpebral edema (HP:0100540) | 1.68575677 |
| 176 | True hermaphroditism (HP:0010459) | 1.68385480 |
| 177 | Stomach cancer (HP:0012126) | 1.68122343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.14895325 |
| 2 | TGFBR2 | 4.55352789 |
| 3 | KIT | 3.19565704 |
| 4 | MYLK | 3.14584905 |
| 5 | ERN1 | 3.03804772 |
| 6 | MAPK15 | 2.67324796 |
| 7 | TNIK | 2.64698774 |
| 8 | EPHB1 | 2.42864826 |
| 9 | TEC | 2.35919962 |
| 10 | TIE1 | 2.30445235 |
| 11 | MAPKAPK5 | 2.26716407 |
| 12 | TYK2 | 2.26095040 |
| 13 | PINK1 | 2.03570890 |
| 14 | BTK | 1.88585941 |
| 15 | ACVR1B | 1.87543840 |
| 16 | MAPKAPK3 | 1.85970302 |
| 17 | MUSK | 1.84712251 |
| 18 | EPHB2 | 1.73479841 |
| 19 | ADRBK1 | 1.72098472 |
| 20 | DAPK2 | 1.71924555 |
| 21 | TXK | 1.65791791 |
| 22 | MAP4K2 | 1.64444474 |
| 23 | TGFBR1 | 1.63635226 |
| 24 | NLK | 1.57751918 |
| 25 | CASK | 1.56866173 |
| 26 | WNK4 | 1.56476397 |
| 27 | INSRR | 1.55144558 |
| 28 | ADRBK2 | 1.51709712 |
| 29 | TBK1 | 1.51702283 |
| 30 | IKBKE | 1.50227651 |
| 31 | MAP3K14 | 1.44121694 |
| 32 | IRAK4 | 1.43982507 |
| 33 | MST4 | 1.43552731 |
| 34 | FLT3 | 1.42561535 |
| 35 | CAMK1D | 1.40443401 |
| 36 | LIMK1 | 1.39727979 |
| 37 | FER | 1.34598071 |
| 38 | ITK | 1.32786806 |
| 39 | CSF1R | 1.31964379 |
| 40 | CLK1 | 1.31032631 |
| 41 | STK39 | 1.28011506 |
| 42 | JAK3 | 1.23016459 |
| 43 | GRK7 | 1.22962199 |
| 44 | ERBB3 | 1.18582805 |
| 45 | MAP4K1 | 1.18525546 |
| 46 | ZAP70 | 1.18077283 |
| 47 | PHKG2 | 1.14836971 |
| 48 | PHKG1 | 1.14836971 |
| 49 | SIK2 | 1.14584089 |
| 50 | WNK3 | 1.14514442 |
| 51 | ABL2 | 1.12366049 |
| 52 | IRAK3 | 1.09097480 |
| 53 | PKN1 | 1.08970345 |
| 54 | PIK3CG | 1.08937800 |
| 55 | MAP3K12 | 1.04497318 |
| 56 | LMTK2 | 1.04135337 |
| 57 | EPHA3 | 1.03299636 |
| 58 | CDC42BPA | 1.02513969 |
| 59 | TRPM7 | 1.00988404 |
| 60 | MAP2K2 | 1.00438456 |
| 61 | BMPR2 | 1.00385622 |
| 62 | GRK1 | 1.00110137 |
| 63 | IKBKB | 0.99864153 |
| 64 | KDR | 0.97976993 |
| 65 | OXSR1 | 0.97074663 |
| 66 | CAMK1G | 0.96089326 |
| 67 | JAK1 | 0.93447182 |
| 68 | CAMK4 | 0.93320543 |
| 69 | TTN | 0.93215387 |
| 70 | CAMKK2 | 0.93046288 |
| 71 | CAMK1 | 0.92074797 |
| 72 | MAPK7 | 0.90462987 |
| 73 | PAK3 | 0.90409556 |
| 74 | DDR2 | 0.89589200 |
| 75 | NTRK3 | 0.89200562 |
| 76 | TAOK3 | 0.88472027 |
| 77 | PIK3CA | 0.88442016 |
| 78 | FGFR4 | 0.88105518 |
| 79 | BLK | 0.87200086 |
| 80 | MET | 0.86932073 |
| 81 | LCK | 0.85922389 |
| 82 | BMPR1B | 0.85343964 |
| 83 | SYK | 0.83052774 |
| 84 | FGFR2 | 0.82349390 |
| 85 | TESK1 | 0.81738427 |
| 86 | FES | 0.81717229 |
| 87 | FGR | 0.79410908 |
| 88 | PRKD1 | 0.79203994 |
| 89 | MAPK13 | 0.78767184 |
| 90 | PRKAA2 | 0.78672995 |
| 91 | IRAK1 | 0.76783844 |
| 92 | MAP3K13 | 0.76319419 |
| 93 | CSK | 0.73148898 |
| 94 | MARK1 | 0.73121694 |
| 95 | MATK | 0.70701665 |
| 96 | VRK1 | 0.70536794 |
| 97 | HCK | 0.70073728 |
| 98 | DYRK1B | 0.69989735 |
| 99 | PRKCG | 0.69305754 |
| 100 | DAPK3 | 0.69178509 |
| 101 | PAK2 | 0.67630499 |
| 102 | MKNK1 | 0.64892128 |
| 103 | CHUK | 0.64710181 |
| 104 | MAPK12 | 0.64523967 |
| 105 | PTK2B | 0.64422100 |
| 106 | CDK3 | 0.63820184 |
| 107 | NUAK1 | 0.61622539 |
| 108 | TNK2 | 0.61321206 |
| 109 | TLK1 | 0.60547959 |
| 110 | ROCK1 | 0.59740648 |
| 111 | MAPK4 | 0.59188169 |
| 112 | CAMK2A | 0.59049082 |
| 113 | MOS | 0.58835870 |
| 114 | LYN | 0.57212752 |
| 115 | CDK19 | 0.56411354 |
| 116 | MAPKAPK2 | 0.55908612 |
| 117 | RPS6KA5 | 0.55248202 |
| 118 | MAP2K1 | 0.55156602 |
| 119 | MAP3K7 | 0.54995831 |
| 120 | GRK5 | 0.54975960 |
| 121 | PRKD2 | 0.54830981 |
| 122 | PRKCE | 0.54222274 |
| 123 | PDGFRA | 0.54153799 |
| 124 | MAP3K3 | 0.52996530 |
| 125 | IGF1R | 0.52171389 |
| 126 | STK38 | 0.50864074 |
| 127 | CAMK2B | 0.50796450 |
| 128 | RIPK1 | 0.50197321 |
| 129 | MAP3K11 | 0.49978249 |
| 130 | MAP3K6 | 0.49899021 |
| 131 | MAP2K6 | 0.48760609 |
| 132 | PRKG2 | 0.48760185 |
| 133 | HIPK2 | 0.47497231 |
| 134 | MARK2 | 0.47209829 |
| 135 | PRKACA | 0.46800747 |
| 136 | PDGFRB | 0.46071490 |
| 137 | ZAK | 0.45401500 |
| 138 | NME2 | 0.45211787 |
| 139 | FGFR3 | 0.44984097 |
| 140 | ROCK2 | 0.44436794 |
| 141 | CAMK2G | 0.44325731 |
| 142 | PRKCA | 0.43696292 |
| 143 | EPHA2 | 0.43682678 |
| 144 | RPS6KA2 | 0.42488574 |
| 145 | PRKG1 | 0.42314032 |
| 146 | PTK2 | 0.42020292 |
| 147 | BCKDK | 0.41965405 |
| 148 | RPS6KA6 | 0.41226099 |
| 149 | CAMK2D | 0.41102875 |
| 150 | DYRK2 | 0.40271134 |
| 151 | SIK3 | 0.40225668 |
| 152 | JAK2 | 0.40064721 |
| 153 | PRKACG | 0.37524615 |
| 154 | OBSCN | 0.36643281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41490912 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16985780 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.16653845 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14891782 |
| 5 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 2.08426472 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06401736 |
| 7 | Sulfur relay system_Homo sapiens_hsa04122 | 2.04258153 |
| 8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.01685776 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.92941351 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86424342 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.85570442 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.84748618 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.80497712 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.79334842 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75334118 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.75102737 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74164062 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72446580 |
| 19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67595286 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65877356 |
| 21 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64644648 |
| 22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.63295902 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.61486136 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.61012901 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60678169 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.60447693 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.60265970 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58338169 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55315197 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52469009 |
| 31 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.51073089 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.50673255 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.50106415 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.49772790 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.48008513 |
| 36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.46230999 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46095189 |
| 38 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.41650882 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38518761 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.37439100 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.36831046 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32576747 |
| 43 | Mineral absorption_Homo sapiens_hsa04978 | 1.31432892 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29320626 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27696609 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27577464 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27364474 |
| 48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.25235447 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 1.24051853 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22311965 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.21277453 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.20070707 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.19677382 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19416006 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19152738 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.17892667 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17358471 |
| 58 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16107326 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15547557 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15485841 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.15117287 |
| 62 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.11961848 |
| 63 | Measles_Homo sapiens_hsa05162 | 1.11843820 |
| 64 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11384594 |
| 65 | Morphine addiction_Homo sapiens_hsa05032 | 1.10349188 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09543615 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 1.09086245 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05607845 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03093474 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01330881 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00572450 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.99918876 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98164898 |
| 74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97901857 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97559166 |
| 76 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97292529 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.96809057 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.96787267 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.96730637 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.96418732 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.96138821 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95530738 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.93876464 |
| 84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.91838838 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90688400 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87948793 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85570428 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84971704 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.84909383 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.84790234 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84764092 |
| 92 | Insulin secretion_Homo sapiens_hsa04911 | 0.84098400 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.82498887 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.82466634 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80646511 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79466372 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78953719 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78737080 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78291366 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.76093237 |
| 101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76013446 |
| 102 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.75925485 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75847697 |
| 104 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75049535 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74853033 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.74448883 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73700745 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.73648359 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71283372 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69595850 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69322097 |
| 112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.69265463 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69041875 |
| 114 | Taste transduction_Homo sapiens_hsa04742 | 0.68438918 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68426962 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.68153425 |
| 117 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67425683 |
| 118 | Legionellosis_Homo sapiens_hsa05134 | 0.67199754 |
| 119 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65840234 |
| 120 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65417675 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64966190 |
| 122 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64539037 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.63076508 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63002552 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62963728 |
| 126 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61785902 |
| 127 | Renin secretion_Homo sapiens_hsa04924 | 0.61496056 |
| 128 | Lysosome_Homo sapiens_hsa04142 | 0.61250005 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61212559 |
| 130 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59787050 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59379592 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58238562 |
| 133 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57744247 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56825589 |
| 135 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.55532552 |
| 136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55327495 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54759754 |
| 138 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54473015 |
| 139 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.53930584 |
| 140 | Hepatitis B_Homo sapiens_hsa05161 | 0.52190827 |
| 141 | Shigellosis_Homo sapiens_hsa05131 | 0.51211147 |
| 142 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51008256 |
| 143 | ABC transporters_Homo sapiens_hsa02010 | 0.50311643 |
| 144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.49018217 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48830904 |
| 146 | Axon guidance_Homo sapiens_hsa04360 | 0.48115092 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45527713 |
| 148 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45467793 |
| 149 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.43888055 |
| 150 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43125571 |
| 151 | * Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42567151 |
| 152 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42007101 |
| 153 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40282821 |
| 154 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.39994097 |
| 155 | * Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37337342 |
| 156 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.37237885 |
| 157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36011501 |
| 158 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.35475987 |

